CLGN Projected Dividend Yield
Ord (New)/CollPlant Biotechnologies Ltd ( NASDAQ : CLGN )Collplant Biotechnologies is a regenerative and aesthetic medicine company focused on three dimensional (3D) bioprinting of tissues and organs, and medical aesthetics. Co.'s products and product candidates are based on its recombinant human collagen (rhCollagen) that is produced with its proprietary plant based genetic engineering technology. Co.'s two rhCollagen-based family products lines are: CollPlant rhCollagen-based BioInk for use in the 3D printing of tissues and organs; and aesthetic medicine product line including a dermal filler and breast implants. Co. also markets two of its products in Europe: VergenixSTR, a soft tissue matrix, and VergenixFG, a wound healing flowable gel. 20 YEAR PERFORMANCE RESULTS |
CLGN Dividend History Detail CLGN Dividend News CLGN Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |